EUROPEAN JOURNAL OF HAEMATOLOGY

Molecular pathogenesis of acquired aplastic anemia

Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies

Frequency, characteristics, and outcome of PTLD after allo‐SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH)

Implementation of an NGS‐based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies

The role of iron repletion in adult iron deficiency anemia and other diseases

Stratification by MYC expression has prognostic impact in MYC translocated B‐cell lymphoma—Identifies a subgroup of patients with poor outcome

Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort study

Estimation of minimally important differences and responder definitions for EORTC QLQ‐MY20 scores in multiple myeloma patients

Role of virological serum markers in patients with both hepatitis B virus infection and diffuse large B‐cell lymphoma

Targeted therapy of BRAF V600E‐mutant histiocytic sarcoma: A case report and review of the literature

Survival of early posthematopoietic stem cell transplantation relapse of myeloid malignancies

Impact of cyclosporine A concentration on acute graft‐vs‐host disease incidence after haploidentical hematopoietic cell transplantation

Invasive fungal disease in patients undergoing umbilical cord blood transplantation after myeloablative conditioning regimen

Clarithromycin added to bortezomib‐cyclophosphamide‐dexamethasone impairs health‐related quality of life in multiple myeloma patients

Immunosuppressive therapy (IST) in adult patients with acquired aplastic anemia (AA): A single‐center experience over the past 15 years

Hematopoietic stem cell mobilization following PD‐1 blockade: Cytokine release syndrome after transplantation managed with ascorbic acid

Transfusion strategies in patients with cirrhosis

The efficacy and safety of modified bortezomib‐lenalidomide‐dexamethasone in transplant‐eligible patients with newly diagnosed multiple myeloma

Risks and challenges of CML management during pregnancy: Looking for a balanced decision

Efficacy and safety of anagrelide as a first‐line drug in cytoreductive treatment‐naïve essential thrombocythemia patients in a real‐world setting

Prophylaxis of chemotherapy‐induced neutropenia and febrile neutropenia with lipegfilgrastim in patients with non‐Hodgkin lymphoma (NADIR study)

Bortezomib consolidation following autologous transplant in younger and older patients with newly diagnosed multiple myeloma in two phase III trials

Postsurgical thrombotic microangiopathy: Case series and review of the literature

Reactivation and dynamics of cytomegalovirus and Epstein‐Barr virus after rabbit antithymocyte globulin and cyclosporine for aplastic anemia

Impact of central nervous system involvement in AML on outcomes after allotransplant and utility of pretransplant cerebrospinal fluid assessment

A study of selected hematopoietic stem cell donors provided by an intermediate size registry

A comparative analysis of the safety profile of direct oral anticoagulants using the FDA adverse event reporting system

Daratumumab added to standard of care in patients with newly diagnosed multiple myeloma: A network meta‐analysis

Circulating extracellular vesicle‐associated CD163 and CD206 in multiple myeloma

Disease progression and defects in primary hemostasis as major cause of bleeding in multiple myeloma

Safety and effectiveness of mogamulizumab in relapsed or refractory adult T‐cell leukemia‐lymphoma

The role and contribution of clonality studies in the diagnosis of lymphoproliferative disorders

Update of the GIMEMA MDS0306 study: Deferasirox for lower risk transfusion‐dependent patients with myelodysplastic syndromes

Comparative risk of major bleeding with rivaroxaban and warfarin: Population‐based cohort study of unprovoked venous thromboembolism

Characteristics and outcome of adult patients with acute promyelocytic leukemia and increased body mass index treated with the PETHEMA Protocols

Association of CD204+ macrophages with poor outcomes of malignant lymphomas not in remission treated by allogeneic HCT

Candida colonization is associated with severe acute GVHD in adult patients undergoing single‐unit cord blood transplantation

Age at diagnosis is an important prognostic factor in Philadelphia‐negative Myeloproliferative Neoplasms

Evaluation of the MD Anderson tumor score for diffuse large B‐cell lymphoma in the rituximab era

A novel mutation in erythropoietin receptor gene (c.1308_1309insG) in an Indian patient with erythrocytosis

HbS/β+ thalassemia: Really a mild disease? A National survey from the AIEOP Sickle Cell Disease Study Group with genotype‐phenotype correlation

Quantification of IGF‐1 receptor is useful in the differential diagnosis of essential thrombocytosis from reactive thrombocytosis

Hypercobalaminemia in myeloid and lymphoid malignancies

HIV‐1 inhibits haematopoiesis via microRNA secreted by virus‐infected CD4+ T cells

Successful autografting with enhanced circulating haemopoietic stem cell yields obtained during response to retreatment in relapsed aplastic anaemia

Outcome and characteristics of non‐measurable myeloma: A cohort study with population‐based data from the Swedish Myeloma Registry

Late polycythemic transformation in JAK2‐mutated essential thrombocythemia patients—characteristics along with a validation of 2016 WHO criteria